2016 ROTH Oncology - MeetMaxVascular Biogenics Ltd. VBLT Viralytics Ltd. VLA Subject to Change | As...
1
/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / Aduro BioTech, Inc. ADRO Argos Therapeutics, Inc. ARGS *Celldex Therapeutics, Inc. CLDX Fate Therapeutics, Inc. FATE Fortress Biotech, Inc. FBIO Lion Biotechnologies, Inc. LBIO MacroGenics, Inc. MGNX Nektar Therapeutics NKTR Pieris Pharmaceuticals, Inc. PIRS Sorrento Therapeutics, Inc. SRNE Stemline Therapeutics, Inc. STML Syndax Pharmaceuticals, Inc. SNDX TG Therapeutics, Inc. TGTX Vascular Biogenics Ltd. VBLT Viralytics Ltd. VLA Subject to Change | As of 10/31/16 *Not Confirmed Company RSVP Registration is open to ROTH clients only. For more information and hotel details, please contact your ROTH sales professional at 1.800.933.6830 or e-mail [email protected] INVITED COMPANIES ROTH Innovations in Oncology Corporate Access Day New York City, NY | November 17, 2016 ROTH Capital Partners, Research Analysts: Joseph Pantginis, Ph.D., Michael Higgins and Mark Breidenbach, Ph.D., invite you to join us for our taking place Thursday, November 17, 2016 in New York City, NY. This event will provide investors the opportunity to meet with senior management teams of a select group of small and mid-cap companies in the Oncology and Targeted Therapies sectors. In addition, they will attend a keynote luncheon with Oncology expert Sotirios G. Stergiopoulos, MD, MBEE,Vice President and Head of Global Medical Affairs Oncology at Shire. Dr. Stergiopoulos is the Head of the GMA Oncology strategy and works closely and in compliance with the commercial organization to facilitate a cohesive medical and marketing strategy for the Company’s Oncology medicines. ROTH Innovations in Oncology Corporate Access Day SPONSORS: This is not an offer or solicitation of the securities herein. VENUE Wednesday | November 16, 2016 Thursday | November 17, 2016 Lotte New York Palace Hotel 455 Madison Ave New York, NY 10022 Additional hotel information & booking information will be provided upon registration 6:30PM | Networking Dinner 8:00AM - 9:00AM | Morning Coffee 9:00AM - 4:45PM | 1-on-1 / Small Group Meetings 12:00PM - 1:00PM | Oncology Keynote Luncheon with Dr. Sotirios G. Stergiopoulos, MD, MBEE
Transcript of 2016 ROTH Oncology - MeetMaxVascular Biogenics Ltd. VBLT Viralytics Ltd. VLA Subject to Change | As...
////////////////////////////////////////////////////
Aduro BioTech, Inc. ADROArgos Therapeutics, Inc. ARGS*Celldex Therapeutics, Inc. CLDXFate Therapeutics, Inc. FATEFortress Biotech, Inc. FBIOLion Biotechnologies, Inc. LBIOMacroGenics, Inc. MGNXNektar Therapeutics NKTRPieris Pharmaceuticals, Inc. PIRSSorrento Therapeutics, Inc. SRNEStemline Therapeutics, Inc. STMLSyndax Pharmaceuticals, Inc. SNDXTG Therapeutics, Inc. TGTXVascular Biogenics Ltd. VBLTViralytics Ltd. VLA
Subject to Change | As of 10/31/16*Not Confirmed Company
RSVPRegistration is open to ROTH clients only. For more information and hotel details, please contact your ROTH sales professional at 1.800.933.6830 or e-mail [email protected]
INVITED COMPANIES
ROTH Innovations in Oncology Corporate Access DayNew York City, NY | November 17, 2016
ROTH Capital Partners, Research Analysts: Joseph Pantginis, Ph.D., Michael Higgins and Mark Breidenbach, Ph.D., invite you to join us for our taking place Thursday, November 17, 2016 in New York City, NY.
This event will provide investors the opportunity to meet with senior management teams of a select group of small and mid-cap companies in the Oncology and Targeted Therapies sectors. In addition, they will attend a keynote luncheon with Oncology expert Sotirios G. Stergiopoulos, MD, MBEE,Vice President and Head of Global Medical Affairs Oncology at Shire. Dr. Stergiopoulos is the Head of the GMA Oncology strategy and works closely and in compliance with the commercial organization to facilitate a cohesive medical and marketing strategy for the Company’s Oncology medicines.
ROTH Innovations in Oncology Corporate Access Day
SPONSORS:
This is not an offer or solicitation of the securities herein.
VENUE
Wednesday | November 16, 2016
Thursday | November 17, 2016
Lotte New York Palace Hotel
455 Madison Ave
New York, NY 10022Additional hotel information & booking information will be provided upon registration
6:30PM | Networking Dinner
8:00AM - 9:00AM | Morning Coffee
9:00AM - 4:45PM | 1-on-1 / Small Group Meetings
12:00PM - 1:00PM | Oncology Keynote
Luncheon with Dr. Sotirios G.
Stergiopoulos, MD, MBEE
